Squarepoint’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.97M Buy
110,604
+77,685
+236% +$1.38M ﹤0.01% 1177
2025
Q1
$587K Sell
32,919
-677
-2% -$12.1K ﹤0.01% 1814
2024
Q4
$1M Buy
+33,596
New +$1M ﹤0.01% 1533
2024
Q2
Sell
-331,184
Closed -$5.18M 2823
2024
Q1
$5.18M Buy
331,184
+260,460
+368% +$4.07M 0.01% 682
2023
Q4
$1.06M Buy
70,724
+9,260
+15% +$138K ﹤0.01% 1327
2023
Q3
$993K Buy
61,464
+51,456
+514% +$831K ﹤0.01% 1306
2023
Q2
$415K Sell
10,008
-84,708
-89% -$3.52M ﹤0.01% 1687
2023
Q1
$5.7M Buy
+94,716
New +$5.7M 0.02% 474
2022
Q4
Sell
-20,286
Closed -$1.54M 2526
2022
Q3
$1.54M Buy
+20,286
New +$1.54M 0.01% 896
2022
Q2
Sell
-7,344
Closed -$608K 2477
2022
Q1
$608K Sell
7,344
-32,578
-82% -$2.7M ﹤0.01% 1396
2021
Q4
$3M Sell
39,922
-93,344
-70% -$7.01M 0.01% 691
2021
Q3
$15.5M Buy
133,266
+60,420
+83% +$7.02M 0.04% 203
2021
Q2
$16.2M Buy
72,846
+31,899
+78% +$7.08M 0.06% 179
2021
Q1
$5.41M Buy
40,947
+17,136
+72% +$2.26M 0.03% 399
2020
Q4
$4.12M Buy
23,811
+13,037
+121% +$2.26M 0.03% 463
2020
Q3
$1.2M Sell
10,774
-175,221
-94% -$19.5M 0.02% 857
2020
Q2
$11M Buy
185,995
+176,738
+1,909% +$10.5M 0.18% 144
2020
Q1
$623K Sell
9,257
-23,738
-72% -$1.6M 0.02% 919
2019
Q4
$2.78M Buy
32,995
+22,399
+211% +$1.89M 0.02% 698
2019
Q3
$792K Sell
10,596
-50,004
-83% -$3.74M 0.01% 1343
2019
Q2
$3.83M Buy
60,600
+23,150
+62% +$1.46M 0.04% 532
2019
Q1
$1.8M Buy
37,450
+8,396
+29% +$404K 0.02% 818
2018
Q4
$973K Sell
29,054
-745
-3% -$25K 0.01% 919
2018
Q3
$1.56M Buy
29,799
+2,026
+7% +$106K 0.02% 809
2018
Q2
$869K Sell
27,773
-18,575
-40% -$581K 0.01% 941
2018
Q1
$1.01M Buy
46,348
+30,417
+191% +$663K 0.02% 804
2017
Q4
$322K Buy
+15,931
New +$322K 0.01% 1446